ID   EM-G3
AC   CVCL_5499
SY   EMG3
DR   GEO; GSM81460
DR   Wikidata; Q54832272
RX   PubMed=17063277;
RX   PubMed=17366476;
CC   Population: Caucasian.
CC   Doubling time: ~34 hours (PubMed=17063277).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=17063277; DOI=10.1007/s10549-006-9358-x;
RA   Brozova M., Kleibl Z., Netikova I., Sevcik J., Scholzova E.,
RA   Brezinova J., Chaloupkova A., Vesely P., Dundr P., Zadinova M.,
RA   Krasna L., Matouskova E.;
RT   "Establishment, growth and in vivo differentiation of a new clonal
RT   human cell line, EM-G3, derived from breast cancer progenitors.";
RL   Breast Cancer Res. Treat. 103:247-257(2007).
//
RX   PubMed=17366476; DOI=10.1002/pmic.200600907;
RA   Selicharova I., Smutna K., Sanda M., Ubik K., Matouskova E.,
RA   Bursikova E., Brozova M., Vydra J., Jiracek J.;
RT   "2-DE analysis of a new human cell line EM-G3 derived from breast
RT   cancer progenitor cells and comparison with normal mammary epithelial
RT   cells.";
RL   Proteomics 7:1549-1559(2007).
//